Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Sprout
United Kingdom
- London
- 24/02/2023
- Pre-Seed
- $1,000,000
About Sprout
From just £5,000, access one of the best performing asset classes with handpicked, high-quality venture capital funds.
With your money professionally invested by seasoned fund managers, diversify your portfolio and back the game-changing businesses of tomorrow in just a few clicks.
Why venture capital?
Venture capital has outperformed the FTSE all-share index every year since 2000.
Diversify your portfolio and access professional fund managers in a high-performing asset class uncorrelated with public markets.
HOW IT WORKS
Manage your portfolio online. Simply:
- Browse Sprout’s curated selection of high-quality VC funds
- Invest through Sprout’s platform - commit capital and transact
- Monitor portfolio performance through our regular updates
- Industry Financial Services
- Website https://www.viasprout.com/
- LinkedIn https://www.linkedin.com/company/viasprout/
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)